- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
Completed
Akt Inhibitor MK2206 in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT01481129
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Hopitaux de Paris Vellefaux, Paris, France
- Institut Bergonie Cancer Center Bordeaux, France
- Henri Mondor University-Hospital Center Créteil, France
- Hospital Claude Huriez Chru Lille, France
NCT01926665
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01399840
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +24 more
- Locations
-
- Indiana University Simon Cancer Center Indianapolis, Indiana, United States
- Seattle Cancer Care Alliance Seattle, Washington, United States
- University of Wisconsin Madison, Wisconsin, United States
- University College London London, United Kingdom
Completed
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma
NCT01078142
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Universitätsmedizin Mainz Mainz, Rhineland-Palatinate, Germany
NCT00348140
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +17 more
- Locations
-
- GSK Investigational Site Sun City, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Laguna Hills, California, United States
NCT01569750
- Conditions
- CD20-positive B-cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- New York, United States
- Rochester, New York, United States
- Nashville, Tennessee, United States
- Houston, Texas, United States
Completed
Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma
NCT02276248
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, Beijing Municipality, China
NCT00472420
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- National Institute of Oncology, A Dept of Internal Medicine Budapest, Hungary
- University of Debrecen Medical and Health Science Center, Institute of Internal Medicine, Hematology Debrecen, Hungary
- Petz Aladar Megyei Korhaz; Hematologia Győr, Hungary
- Kaposi Mor Teaching Hospital, Dept of Internal Medicine/Hematology Kaposvár, Hungary
NCT01334502
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Mayo Clinic Cancer Center Rochester, Minnesota, United States